Thanks, Tossy for the updateI hope Sud is ok.It's not good...

First 16543 Last

Share
Profile

Follow
thevinnys

1,958 Posts.

4359

07/08/23

15:29

Post #: 69204562
Share

Originally posted by tossydog: ↑

Hi All,
I requested a top 20 shareholding from the Company, which I have shared below.
It confirms there has been selling, Sud has sold a lot.
On the surface, this is alarming, as I know Sud is a believer in the assets and the companies potential.
I spoke with Joel who confirmed Sud is still very much a believer and supporter but couldn't comment on his financial position and decision to sell.

I am only speculating but something is up with Sud selling & I don't it has anything to do with Incannex. Seems out of character.

Tetra is the only thing connected to Sud that has changed in my brief search of the web - timing of this Tetra announcement seems to tie in with Sud's offloading? https://www.thenewswire.com/press-releases/1AqRFXNg6-tetra-bio-pharma-voluntary-bankruptcy.html

I am only speculating but I don't think Sud want to sell.....

On a positive note, the shares have been sucked up, unfortunately at a lower price than we had all hoped.

Other than share-price frustration, Joel seems very upbeat about the business, the clinical programs & the Clarion Clinics journey commencing.

Expand

Thanks, Tossy for the update

I hope Sud is ok.
It's not good timing for him at all by the looks.
With Tera Bio going into bankruptcy.
It looks like Sud has offloaded about 40M IHL Shares since the last published Top 20 List.

Good luck Dr Sud

IHL Price at posting: 8.6¢ Sentiment: Buy Disclosure: Held
9 Upvote

1 Great analysis

Reply

Top Stories

CC9

Chariot locks in high-potential drill target at Black Mountain, one of the USA's largest lithium landholdings

UNT

UNITH hard launching AI 'digital human' platform too 600+ companies as AI thematic survives sell-off

Banking on ANZ in this week's Hot Stock tips

USL

'Joaquin Silver District' acquisition to become a key asset for Unico

INA

Ingenia shares jump 7% on strong revenue and earnings figures